Tekla Capital Management LLC Apellis Pharmaceuticals, Inc. Transaction History

Tekla Capital Management LLC

$2.53 Billion
Q2 2023

A detailed history of Tekla Capital Management LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Tekla Capital Management LLC holds 173,248 shares of APLS stock, worth $5.11 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

173,248

Previous 135,124 28.21%

Holding current value

$5.11 Million

Previous $8.91 Million 77.09%

% of portfolio

0.62%

Previous 0.34%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$76.68 - $93.31 $2.92 Million - $3.56 Million	38,124 Added 28.21%	173,248 $15.8 Million
Q1 2023 May 10, 2023	BUY	$46.59 - $66.96 $3.2 Million - $4.6 Million	68,698 Added 103.42%	135,124 $8.91 Million
Q4 2022 Feb 10, 2023	SELL	$43.24 - $61.04 $8.63 Million - $12.2 Million	-199,650 Reduced 75.03%	66,426 $3.43 Million
Q3 2022 Nov 01, 2022	SELL	$44.76 - $69.66 $2.06 Million - $3.21 Million	-46,116 Reduced 14.77%	266,076 $18.2 Million
Q2 2022 Jul 29, 2022	BUY	$35.07 - $59.21 $4.08 Million - $6.89 Million	116,372 Added 59.43%	312,192 $14.1 Million
Q3 2021 Nov 12, 2021	BUY	$31.4 - $69.84 $1.36 Million - $3.02 Million	43,282 Added 28.37%	195,820 $6.45 Million
Q1 2021 May 14, 2021	SELL	$40.8 - $57.39 $2.59 Million - $3.64 Million	-63,479 Reduced 29.39%	152,538 $6.55 Million
Q3 2020 Nov 13, 2020	BUY	$25.89 - $33.65 $1.1 Million - $1.43 Million	42,523 Added 24.51%	216,017 $6.52 Million
Q1 2020 May 14, 2020	BUY	$17.91 - $44.33 $761,085 - $1.88 Million	42,495 Added 32.44%	173,494 $4.65 Million
Q4 2019 Feb 13, 2020	BUY	$22.1 - $30.8 $711,951 - $992,222	32,215 Added 32.61%	130,999 $4.01 Million
Q3 2019 Nov 13, 2019	BUY	$24.09 - $32.18 $2.38 Million - $3.18 Million	98,784 New	98,784 $2.38 Million

Others Institutions Holding APLS

# of Institutions

299

Shares Held

113M

Call Options Held

5.21M

Put Options Held

691K

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.24B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Account

Tekla Capital Management LLC Apellis Pharmaceuticals, Inc. Transaction History